Alprostadil

Looking for a reliable source to shop Alprostadil 20mcg? Sino Research Peptide Manufacturer delivers laboratory-grade Alprostadil (Prostaglandin E1) with verified purity and consistent batch quality. Researchers worldwide trust our supply chain for peptides that meet the strictest analytical standards.

If you’re searching for Alprostadil for sale or wondering where to buy Alprostadil, our platform simplifies the process. We provide transparent alprostadil injection price listings and detailed COAs with every order, giving research professionals full confidence in what they receive.

Skip the guesswork of typing ‘buy alprostadil near me’ into search engines. Instead, order directly from Sino Research Peptide Manufacturer — the best place to shop Alprostadil 20mcg online. From alprostadil cream buy online options to Buy Alprostadil Injection Online formats, we support diverse research protocols with fast, discreet shipping and responsive customer service tailored to laboratory professionals.

Alprostadil (Prostaglandin E1): A Research Literature Overview

Alprostadil is a synthetic form of prostaglandin E1 (PGE1), a naturally occurring lipid compound that researchers have extensively studied for its vasodilatory and smooth muscle relaxant properties. As one of the most well-characterized prostaglandins in biomedical research, alprostadil has attracted significant scientific interest for its ability to directly affect vascular smooth muscle through cyclic AMP-mediated signaling pathways. Below, we summarize the pharmacological research behind this compound.

What Is Prostaglandin E1?

Researchers first isolated and characterized prostaglandin E1 in the 1960s, with subsequent decades bringing considerable advances in understanding its pharmacological profile. Alprostadil’s mechanism of action involves binding to specific EP receptors on smooth muscle cells, triggering a cascade of intracellular events that ultimately produce vasodilation. This direct mechanism distinguishes alprostadil from other vasoactive compounds and has made it a valuable research tool for studying vascular physiology.

Chemical Makeup

How Does Alprostadil Work?

Alprostadil functions primarily through activation of adenylate cyclase following binding to EP2 and EP4 prostaglandin receptors. This receptor interaction stimulates production of cyclic adenosine monophosphate (cAMP), which subsequently activates protein kinase A and leads to smooth muscle relaxation. The resulting vasodilation increases blood flow to target tissues, making alprostadil particularly valuable for research into peripheral vascular function and microcirculation dynamics.

Beyond its primary vasodilatory effects, researchers have identified several additional pharmacological properties that expand the compound’s research utility. Alprostadil demonstrates significant antiplatelet activity through inhibition of platelet aggregation, an effect mediated by the same cAMP-dependent pathways responsible for smooth muscle relaxation. This dual action on both vascular smooth muscle and platelet function has generated considerable research interest in understanding the interplay between hemodynamic regulation and thrombotic processes.

Studies have also demonstrated that alprostadil possesses cytoprotective properties, potentially protecting tissues from ischemic damage through mechanisms that extend beyond simple vasodilation. Research suggests prostaglandin E1 may modulate inflammatory responses and oxidative stress, adding further dimensions to its pharmacological profile.

What Does Research Say About Alprostadil?

Alprostadil and Vascular Function

A comprehensive study published in the New England Journal of Medicine investigated the dose-response relationship of alprostadil in models of vascular dysfunction. The study demonstrated significant dose-dependent improvements in vascular response, with higher doses producing more pronounced effects on blood flow parameters. These findings established alprostadil as a reliable research tool for studying vascular physiology and the mechanisms underlying smooth muscle function.

Additional research has explored alprostadil’s effects on peripheral arterial circulation. Studies indicate that prostaglandin E1 infusion may significantly improve microcirculation in experimental models, with measurable increases in tissue oxygenation and metabolic parameters. The compound’s ability to enhance peripheral blood flow has made it particularly valuable for research into conditions characterized by impaired microvascular function.

Alprostadil and Smooth Muscle Relaxation

Researchers have extensively characterized the mechanism by which alprostadil induces smooth muscle relaxation. Studies demonstrate that the compound’s binding to EP receptors triggers a well-defined intracellular signaling cascade, beginning with adenylate cyclase activation and culminating in myosin light chain dephosphorylation. This molecular pathway results in reduced calcium sensitivity and subsequent relaxation of vascular smooth muscle fibers.

Research conducted by Narumiya and colleagues provided detailed insights into the receptor pharmacology underlying alprostadil’s effects. Their work demonstrated that different EP receptor subtypes contribute distinct aspects to the overall physiological response, with EP2 and EP4 receptors playing predominant roles in vasodilation, while other subtypes may modulate additional cellular responses. This receptor selectivity profile continues to inform research into prostaglandin biology.

Alprostadil and Microcirculation Research

Recent research has examined alprostadil’s potential effects on microcirculatory function across various experimental contexts. A systematic review and meta-analysis published in 2024 evaluated the efficacy of prostaglandin E1 in modulating microcirculatory parameters. The analysis, encompassing multiple controlled studies, found that alprostadil supplementation was associated with improved microvascular flow indices and reduced incidence of flow disturbances in experimental models.

Laser Doppler imaging studies have provided additional evidence for alprostadil’s effects on peripheral microcirculation. Research examining topical application of the compound demonstrated measurable increases in cutaneous blood flow, suggesting alprostadil may influence microvascular tone through both systemic and local mechanisms. These findings have expanded understanding of prostaglandin E1’s vascular effects and opened new avenues for microcirculatory physiology research.

Alprostadil Pharmacokinetics

Pharmacokinetic studies have characterized alprostadil’s absorption, distribution, metabolism, and elimination profile. Research conducted in controlled study settings demonstrated dose-proportional kinetics across a range of intravenous infusion rates, with plasma concentrations increasing linearly with administered dose. The compound exhibits rapid metabolism, with conversion to inactive metabolites occurring primarily through oxidation of the 15-hydroxyl group, resulting in a relatively short plasma half-life.

This rapid metabolism has important implications for research applications, as it allows for precise temporal control of vasodilatory effects and minimizes the potential for accumulation during extended experimental protocols. Understanding these pharmacokinetic properties enables researchers to design studies that account for the compound’s brief duration of action.

A Note on This Page

Alprostadil is an approved prescription medication used clinically under the brand names Caverject, Edex, and Vitaros, among others, for erectile dysfunction. This page summarizes published pharmacological and vascular research literature only — it does not describe a product available through Sino Research Peptide Manufacturer, and nothing here constitutes dosing, administration, or purchasing guidance. Anyone considering treatment involving this compound should speak with a licensed healthcare provider.

References:

1. NCBI Bookshelf. Alprostadil. StatPearls Publishing. 2025. shop Alprostadil 20mcg
2. DrugBank. Alprostadil: Mechanism of Action. DrugBank Online. 2024. shop Alprostadil 20mcg
3. Narumiya S, et al. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79(4):1193-1226. shop Alprostadil 20mcg
4. Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. shop Alprostadil 20mcg
5. Schror K. Mechanisms of action of prostaglandin E1 in peripheral arterial disease. Vasa. 2003;32(4):203-208. shop Alprostadil 20mcg
6. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil. N Engl J Med. 1996;334(14):873-877. shop Alprostadil 20mcg
7. Porst H. Int J Impot Res. 2002;14(Suppl 1):S53-S63. shop Alprostadil 20mcg
8. Anaissie J, Hellstrom WJ. Clinical use of alprostadil topical cream. Res Rep Urol. 2016;8:123-131. shop Alprostadil 20mcg
9. Narumiya S, et al. Physiol Rev. 1999;79(4):1193-1226. shop Alprostadil 20mcg
10. Wang H, et al. Efficacy and Safety of Alprostadil in Microcirculatory Disturbances. Cardiovasc Drugs Ther. 2024. shop Alprostadil 20mcg
11. ISRCTN Registry. Topical alprostadil in patients with systemic sclerosis. ISRCTN99737999. shop Alprostadil 20mcg
12. Brecht HM, et al. Dose proportional pharmacokinetics of alprostadil. Br J Clin Pharmacol.  1995;40(1):73-78. shop Alprostadil 20mcg
13. Cawello W, et al. Alprostadil cream in erectile dysfunction. Drug Des Devel Ther. 2016;10:2585-2594. shop Alprostadil 20mcg

Alprostadil (Prostaglandin E1) is available for research and laboratory purposes only.